Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib ...Middle East

PR Newswire - News
Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib
Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency This submission follows the grant of accelerated assessment allowing an expedited review for leniolisib from a standard 210 days to 150 days...

Hence then, the article about pharming submits a marketing authorisation application to the european medicines agency for leniolisib was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News